ホモパントテン酸の臨床応用 : (II)脳性小児まひおよび脳炎後遺症にたいする長期使用

概要

論文の詳細を見る
Homopantothenic acid was given orally in a dose of 1g/day for 1-38 months (mean 8.8 months) in 54 cases of cerebral palsy and 21 cases of postencephalitic sequelae and the following results were obtained. The rates of effectiveness were 75% clinically and 66% electroencephalographically. In the electroencephalogram, a trend for normalization of the slow wave dysrrhythmia was already present after one month of medication and a trend for improvement in the asymmetry, low voltage and spike discharge was noted by treatment of 6 months or more. Eleven similar cases were followed for 3-18 months (mean 9.1 month) without administration of homopantothenic acid as the control group but no trend for improvement was observed and on the contrary, some of the cases showed exacerbation. No side effects were observed in any of the cases given homopantothenic acid.
日本ビタミン学会の論文
1968-03-25